Loading…
Crystallinity improvement of room-temperature PLD-deposited ZnO thin films on cyclo-olefin polymer substrates subject to surface-pretreatment with vacuum-UV-light irradiation
Oga, Tomoaki, Kai, Ryoya, Kaneko, Naho, Miyazaki, Hisashi, Kaneko, Satoru, Matsuda, Akifumi, Yoshimoto, Mamoru
Published in Journal of crystal growth (01.02.2023)
Published in Journal of crystal growth (01.02.2023)
Get full text
Journal Article
Loading…
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysis
Monk, Bradley J., Herzog, Thomas J., Kaye, Stanley B., Krasner, Carolyn N., Vermorken, Jan B., Muggia, Franco M., Pujade-Lauraine, Eric, Park, Youn C., Parekh, Trilok V., Poveda, Andres M.
Published in European journal of cancer (1990) (01.10.2012)
Published in European journal of cancer (1990) (01.10.2012)
Get full text
Journal Article
Loading…
Genome-wide analysis of the apple PLD gene family and a functional characterization of MdPLD17 in drought tolerance
Fang, Sen, Han, Xuanxuan, Yuan, Penghao, Song, Chunhui, Song, Shangwei, Jiao, Jian, Wang, Miaomiao, Zheng, Xianbo, Bai, Tuanhui
Published in Scientia horticulturae (01.11.2023)
Published in Scientia horticulturae (01.11.2023)
Get full text
Journal Article
Loading…
A randomized, double-blind, placebo-controlled, phase II study to assess the efficacy and safety of farletuzumab (MORAb-003) in combination with carboplatin plus either paclitaxel or pegylated liposomal doxorubicin (PLD) in subjects with low CA125 platinum-sensitive ovarian cancer
Herzog, Thomas J., Ghamande, Sharad A., Gabra, Hani, Armstrong, Deborah Kay, Fujiwara, Keiichi, Monk, Bradley J., Pignata, Sandro, Gonzalez-Martin, Antonio, Sehouli, Jalid, Schweizer, Charles, Weil, Susan, Hoffman, Kimberly, Grasso, Luigi, Coleman, Robert L., Vergote, Ignace
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Loading…
Design of a PLD-grown Y2O3 protective barrier for fusion relevant applications
Paladino, Boris, Vanazzi, Matteo, Iadicicco, Daniele, Perinot, Andrea, Caironi, Mario, Ceseracciu, Luca, Reccagni, Pierfranco, Bassini, Serena, Utili, Marco, Fonzo, Fabio Di
Published in Nuclear fusion (01.10.2020)
Published in Nuclear fusion (01.10.2020)
Get full text
Journal Article
Loading…
PRECEDENT: A randomized phase II trial comparing EC145 and pegylated liposomal doxorubicin (PLD) in combination, versus PLD alone, in subjects with platinum-resistant ovarian cancer
Naumann, R. W., Coleman, R. L., Burger, R. A., Herzog, T. J., Morris, R., Sausville, E. A., Kutarska, E., Ghamande, S. A., Gabrail, N. Y., De Pasquale, S., Nowara, E., Gilbert, L., Caton, J. R., Gersh, R. H., Teneriello, M. G., Harb, W. A., Konstantinopoulos, P., Symanowski, J. T., Lovejoy, C., Messmann, R. A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Loading…
A randomized, double-blind, placebo-controlled, phase II study to assess the efficacy/safety of farletuzumab in combination with carboplatin plus paclitaxel or carboplatin plus pegylated liposomal doxorubicin (PLD) in women with low CA-125 platinum-sensitive ovarian cancer
Herzog, Thomas, Pignata, Sandro, Ghamande, Sharad, Rubio, Maria-Jesus, Fujiwara, Keiichi, Vulsteke, Christof, Armstrong, Deborah, Sehouli, Jalid, Coleman, Robert, Gabra, Hani, Scambia, Giovanni, Monk, Bradley, Arija, Jose Angel, Ushijima, Kimio, Hanna, Rabbie, Zamagni, Claudio, Wenham, Robert, Gonzalez-Martin, Antonio, Slomovitz, Brian, Jia, Yan, Ramsay, Lisa, Tewari, Krishnansu, Weil, Susan, Vergote, Ignace
Published in Gynecologic oncology (01.08.2021)
Published in Gynecologic oncology (01.08.2021)
Get full text
Journal Article
Loading…
PRECEDENT: A randomized phase II trial comparing EC145 and pegylated liposomal doxorubicin (PLD) in combination, versus PLD alone, in subjects with platinum-resistant ovarian cancer
Naumann, R. W., Symanowski, J. T., Ghamande, S. A., Gabrail, N. Y., Gilbert, L., Teneriello, M. G., Sutton, G., Lovejoy, C., Messmann, R. A.
Published in Journal of clinical oncology (20.06.2010)
Published in Journal of clinical oncology (20.06.2010)
Get full text
Journal Article
Loading…
Phase I safety study of farletuzumab, carboplatin, and pegylated liposomal doxorubicin (PLD) in subjects with platinum-sensitive epithelial ovarian cancer (EOC)
Jelovac, D., Armstrong, D. K., Weil, S., Phillips, M., Schwartz, B. M., Estes, J. M., Alvarez, R. D.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Loading…
Adverse event profile by therapy cycle for vintafolide plus pegylated liposomal doxorubicin (PLD) versus PLD alone in platinum-resistant ovarian cancer
Symanowski, James Thomas, Kutarska, Elzbieta, Bidzinski, Mariusz, Nguyen, Binh, Rangwala, Reshma A., Naumann, R. Wendel
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Loading…
Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin (PLD): Use of left ventricular ejection fraction (EF)
Skubitz, Keith M., Blaes, Anne Hudson, Konety, Suma, Francis, Gary S.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Loading…
A randomized, double-blind, placebo-controlled, phase II study to assess the efficacy and safety of farletuzumab (MORAb-003) in combination with carboplatin plus either paclitaxel or pegylated liposomal doxorubicin (PLD) in subjects with low CA125 platinum-sensitive ovarian cancer
Sharad A. Ghamande, Robert L. Coleman, Susan C. Weil, Kimberly Hoffman, Antonio González-Martín, Ignace Vergote, Luigi Grasso, Hani Gabra, Bradley J. Monk, Keiichi Fujiwara, Deborah K. Armstrong, Jalid Sehouli, Sandro Pignata, Thomas J. Herzog, Charles Schweizer
Published in Journal of Clinical Oncology (20.05.2016)
Published in Journal of Clinical Oncology (20.05.2016)
Get full text
Journal Article
Loading…
Effect of varying laser energy density at LaScO3/SrTiO3 interface
Nehra, Simran, Shrivastava, Shikha, Gangwar, Sunil, Manral, Pooja, Yadav, C S, Malik, V K, Dogra, Anjana
Published in Journal of physics. Condensed matter (14.04.2025)
Published in Journal of physics. Condensed matter (14.04.2025)
Get full text
Journal Article
Loading…
Final survival results of the randomized phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer
Monk, B. J., Herzog, T. J., Kaye, S. B., Krasner, C. N., Vermorken, J. B., Muggia, F., Pujade-Lourraine, E., Zintl, P., Parekh, T. V., Poveda, A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Loading…
Exploring label dynamics of velocity‐selective arterial spin labeling in the kidney
Bones, Isabell K., Franklin, Suzanne L., Harteveld, Anita A., Osch, Matthias J. P., Schmid, Sophie, Hendrikse, Jeroen, Moonen, Chrit, Stralen, Marijn, Bos, Clemens
Published in Magnetic resonance in medicine (01.07.2021)
Published in Magnetic resonance in medicine (01.07.2021)
Get full text
Journal Article
Loading…
A randomized, double-blind, placebo-controlled, phase II study to assess the efficacy/safety of farletuzumab in combination with carboplatin plus paclitaxel or carboplatin plus pegylated liposomal doxorubicin (PLD) in women with low CA-125 platinum-sensitive ovarian cancer
Robert M. Wenham, Antonio González-Martín, Ignace Vergote, Keiichi Fujiwara, Kimio Ushijima, Susan Weil, Claudio Zamagni, Christof Vulsteke, Bradley J. Monk, Jose Angel Arija, Lisa Ramsay, Robert E. Coleman, Rabbie K. Hanna, Giovanni Scambia, Krishnansu S. Tewari, Sharad A. Ghamande, Maria-Jesus Rubio, Jalid Sehouli, Sandro Pignata, Hani Gabra, Yan Jia, Deborah K. Armstrong, Brian M. Slomovitz, Thomas J. Herzog
Published in Gynecologic Oncology (01.08.2021)
Published in Gynecologic Oncology (01.08.2021)
Get full text
Journal Article
Loading…
Loading…
Circulating tumor cells (CTC) in a study of relapsed/recurrent advanced ovarian cancer: An exploratory analysis in the ova-301 phase III study of pegylated liposomal doxorubicin (PLD) compared with trabectedin and PLD
Poveda, A., Kaye, S. B., McCormack, R. T., Wang, S., Ricci, D., Broderick, E., Parekh, T., Lebedinsky, C., Tecero, J. C., Monk, B. J.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Loading…
Loading…
Serum bile acids associate with liver volume in polycystic liver disease and decrease upon treatment with lanreotide
Dekker, Shosha E. I., Bierau, Jörgen, Giera, Martin, Blomberg, Niek, Drenth, Joost P. H., Mayboroda, Oleg A., Fijter, Johan W., Soonawala, Darius, Drenth, Joost P. H., Fijter, Johan W., Gansevoort, Ron T., Meijer, Esther, Peters, Dorien J.M., Wetzels, Jack F., Zietse, Robert
Published in European journal of clinical investigation (01.04.2024)
Published in European journal of clinical investigation (01.04.2024)
Get full text
Journal Article